Immutep Ltd Adr Stock Performance

IMMP Stock  USD 2.73  0.24  8.08%   
On a scale of 0 to 100, Immutep holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 1.23, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immutep will likely underperform. Please check Immutep's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Immutep's current trending patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Immutep Ltd ADR are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak primary indicators, Immutep reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(8.08)
Five Day Return
(15.22)
Year To Date Return
(7.46)
Ten Year Return
(74.65)
All Time Return
(97.96)
Last Split Factor
3:10
Dividend Date
2016-12-28
Last Split Date
2016-12-28
1
Prima BioMed Stock Price Crosses Below 50-Day Moving Average Should You Sell
11/11/2025
2
Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium
12/02/2025
3
Immutep Limited Firm Reports Positive Data from Trials
12/10/2025
4
Immutep Announces Strong Operational Progress in Global TACTI-004 Phase III and Enrolment Continues at Robust Pace
12/16/2025
5
Why Wall Street Is Watching Immuteps Experimental Autoimmune Treatment Closely - Sahm
12/23/2025
6
Immutep Quarterly Activities Report Q2 FY26
01/29/2026
Begin Period Cash Flow161.8 M
Total Cashflows From Investing Activities-38.5 M

Immutep Relative Risk vs. Return Landscape

If you would invest  183.00  in Immutep Ltd ADR on November 3, 2025 and sell it today you would earn a total of  90.00  from holding Immutep Ltd ADR or generate 49.18% return on investment over 90 days. Immutep Ltd ADR is currently generating 0.7663% in daily expected returns and assumes 5.0779% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Immutep, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Immutep is expected to generate 6.85 times more return on investment than the market. However, the company is 6.85 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Immutep Target Price Odds to finish over Current Price

The tendency of Immutep Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.73 90 days 2.73 
about 27.43
Based on a normal probability distribution, the odds of Immutep to move above the current price in 90 days from now is about 27.43 (This Immutep Ltd ADR probability density function shows the probability of Immutep Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.23 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immutep will likely underperform. Additionally Immutep Ltd ADR has an alpha of 0.5041, implying that it can generate a 0.5 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Immutep Price Density   
       Price  

Predictive Modules for Immutep

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immutep Ltd ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.142.737.81
Details
Intrinsic
Valuation
LowRealHigh
0.132.577.65
Details
Naive
Forecast
LowNextHigh
0.062.958.02
Details
2 Analysts
Consensus
LowTargetHigh
8.659.5010.55
Details

Immutep Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immutep is not an exception. The market had few large corrections towards the Immutep's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immutep Ltd ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immutep within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.50
β
Beta against Dow Jones1.23
σ
Overall volatility
0.55
Ir
Information ratio 0.10

Immutep Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immutep for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immutep Ltd ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Immutep Ltd ADR is way too risky over 90 days horizon
Immutep Ltd ADR appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 5.04 M. Net Loss for the year was (61.43 M) with loss before overhead, payroll, taxes, and interest of (56.37 M).
Immutep Ltd ADR currently holds about 80 M in cash with (62.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92.
Latest headline from globenewswire.com: Immutep Quarterly Activities Report Q2 FY26

Immutep Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immutep Stock often depends not only on the future outlook of the current and potential Immutep's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immutep's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding145.6 M
Cash And Short Term Investments129.7 M

Immutep Fundamentals Growth

Immutep Stock prices reflect investors' perceptions of the future prospects and financial health of Immutep, and Immutep fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immutep Stock performance.

About Immutep Performance

Assessing Immutep's fundamental ratios provides investors with valuable insights into Immutep's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Immutep is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand(225.45)(214.18)
Return On Tangible Assets(0.37)(0.39)
Return On Capital Employed(0.79)(0.83)
Return On Assets(0.35)(0.37)
Return On Equity(0.38)(0.40)

Things to note about Immutep Ltd ADR performance evaluation

Checking the ongoing alerts about Immutep for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immutep Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Immutep Ltd ADR is way too risky over 90 days horizon
Immutep Ltd ADR appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 5.04 M. Net Loss for the year was (61.43 M) with loss before overhead, payroll, taxes, and interest of (56.37 M).
Immutep Ltd ADR currently holds about 80 M in cash with (62.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92.
Latest headline from globenewswire.com: Immutep Quarterly Activities Report Q2 FY26
Evaluating Immutep's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Immutep's stock performance include:
  • Analyzing Immutep's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immutep's stock is overvalued or undervalued compared to its peers.
  • Examining Immutep's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Immutep's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immutep's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Immutep's stock. These opinions can provide insight into Immutep's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Immutep's stock performance is not an exact science, and many factors can impact Immutep's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.